Raising Health Andrew Huberman: Peptides, Sleep Tech, and the End of Obesity
105 snips
Mar 9, 2026 
Andrew Huberman, Stanford neurobiology and ophthalmology professor who turns neuroscience into practical health tips. He talks peptides and GLP-1s and what they mean for obesity. He explores sleep tech that could speed sleep and wearables that read biology. He previews focus drugs, personalized peptide mixes, and neurotechnologies that may let us ‘write’ our biology soon.
AI Snips
Chapters
Transcript
Episode notes
Pandemic Sparked Self-Directed Health Movement
- The pandemic accelerated a consumer health revolution as people sought actionable ways to protect themselves beyond traditional medicine.
- Vitamin D, melatonin, resistance training, protein, creatine, and curiosity about supplements normalized self-directed health practices that persisted after COVID.
Use Light And Breathing To Regulate Mood
- Use simple, mechanism-based tools to control anxiety and circadian biology, like long-exhale breathing to slow heart rate via the vagus nerve.
- Bright days and dark nights strongly protect mental health, so prioritize daytime light exposure and dim evenings.
GLPs Could Reshape Obesity Landscape
- GLP drugs (like retitrutide) can dramatically lower obesity prevalence by enabling substantial weight loss without exercise.
- Compounding and gray-market sourcing already let many take lower-dose GLPs, challenging traditional pricing and access.